BioBridgeXAll companies

Soligenix, Inc.

Pharmaceutical company · Princeton, New Jersey, United States · Nasdaq: SNGX

Soligenix, Inc. is a pharmaceutical company headquartered in Princeton, New Jersey, United States. Its shares trade on Nasdaq under the ticker SNGX. It has received 11 US government small-business research awards (SBIR/STTR) from health agencies, $7.1 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $2 million sold in a notice filed in 2017.

www.soligenix.comProfile compiled from public records. Is this your company? Request a correction or update

Soligenix at a glance

Typepharmaceutical company
HeadquartersPrinceton, New Jersey, United States
Stock listingNasdaq: SNGX
SEC industryPharmaceutical Preparations
Employees (per SBIR records)10
SEC CIK812796

What does Soligenix do?

US government research funding

11 SBIR/STTR small-business research awards from US health agencies, $7.1 million in total (2003 to 2021). NIH funding came from the National Institute of Dental and Craniofacial Research, National Cancer Institute, National Institute of Allergy and Infectious Diseases.

Private fundraising reported to the SEC

7 Form D notices; the most recent reported $2 million sold (2017).

Frequently asked questions about Soligenix

Where is Soligenix headquartered?

Soligenix, Inc. is headquartered in Princeton, New Jersey, United States.

What does Soligenix do?

Soligenix, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Soligenix a public company?

Yes. Soligenix, Inc. trades on Nasdaq under the ticker SNGX.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.